Skip to main content

Published locations for START trial keeps L-BLP25 immunotherapy alive in stage III NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. START trial keeps L-BLP25 immunotherapy alive in stage III NSCLC

User login

  • Reset your password
  • /content/start-trial-keeps-l-blp25-immunotherapy-alive-stage-iii-nsclc
  • /internalmedicinenews/article/65620/oncology/start-trial-keeps-l-blp25-immunotherapy-alive-stage-iii
  • /oncologypractice/article/65620/oncology/start-trial-keeps-l-blp25-immunotherapy-alive-stage-iii
  • /hematology-oncology/article/65620/oncology/start-trial-keeps-l-blp25-immunotherapy-alive-stage-iii
  • /internalmedicine/article/65620/oncology/start-trial-keeps-l-blp25-immunotherapy-alive-stage-iii